Why is melanoma so metastatic? (Q38150869)

29 August 2017

Why is melanoma so metastatic? (English)

1 reference

29 August 2017

Russell R Braeuer

1

1 reference

29 August 2017

Ian R Watson

2

1 reference

29 August 2017

Chang-Jiun Wu

3

1 reference

29 August 2017

Aaron K Mobley

4

1 reference

29 August 2017

Takafumi Kamiya

5

1 reference

29 August 2017

Einav Shoshan

6

1 reference

29 August 2017

Menashe Bar-Eli

7

1 reference

29 August 2017

17 October 2013

1 reference

Pigment Cell & Melanoma Research

29 August 2017

1 reference

29 August 2017

27

1 reference

29 August 2017

1

1 reference

29 August 2017

19-36

1 reference

Microvesicle entry into marrow cells mediates tissue-specific changes in mRNA by direct delivery of mRNA and induction of transcription

29 August 2017

1 reference

https://api.crossref.org/works/10.1111%2FPCMR.12172

Steps toward mapping the human vasculature by phage display.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FPCMR.12172

Murine melanoma-infiltrating dendritic cells are defective in antigen presenting function regardless of the presence of CD4CD25 regulatory T cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FPCMR.12172

B7-H1 is a ubiquitous antiapoptotic receptor on cancer cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FPCMR.12172

Melanoma revives an embryonic migration program to promote plasticity and invasion

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FPCMR.12172

Final version of 2009 AJCC melanoma staging and classification

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FPCMR.12172

Selective BRAFV600E inhibition enhances T-cell recognition of melanoma without affecting lymphocyte function

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FPCMR.12172

Transcriptional control of melanoma metastasis: the importance of the tumor microenvironment

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FPCMR.12172

The sweet and bitter sides of galectins in melanoma progression

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FPCMR.12172

Galectin-3 contributes to melanoma growth and metastasis via regulation of NFAT1 and autotaxin

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FPCMR.12172

Isolation and identification of platelet-activating factor in UV-irradiated guinea pig skin

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FPCMR.12172

T-cell recognition of melanoma-associated antigens

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FPCMR.12172

Human CD271-positive melanoma stem cells associated with metastasis establish tumor heterogeneity and long-term growth

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FPCMR.12172

Shedding microvesicles: artefacts no more

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FPCMR.12172

RAC1P29S is a spontaneously activating cancer-associated GTPase

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FPCMR.12172

A galectin-3 ligand corrects the impaired function of human CD4 and CD8 tumor-infiltrating lymphocytes and favors tumor rejection in mice

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FPCMR.12172

Silencing cAMP-response element-binding protein (CREB) identifies CYR61 as a tumor suppressor gene in melanoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FPCMR.12172

Tumor-associated B7-H1 promotes T-cell apoptosis: a potential mechanism of immune evasion

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FPCMR.12172

Lack of HLA class I antigen expression by cultured melanoma cells FO-1 due to a defect in B2m gene expression

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FPCMR.12172

Tumors: wounds that do not heal. Similarities between tumor stroma generation and wound healing

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FPCMR.12172

Polymorphonuclear neutrophil-derived ectosomes interfere with the maturation of monocyte-derived dendritic cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FPCMR.12172

Role of transforming growth factor Beta in human cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FPCMR.12172

VEGF-targeted therapy: mechanisms of anti-tumour activity.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FPCMR.12172

MEK1 mutations confer resistance to MEK and B-RAF inhibition

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FPCMR.12172

Exosomes: endosomal-derived vesicles shipping extracellular messages

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FPCMR.12172

BRAF inhibition is associated with enhanced melanoma antigen expression and a more favorable tumor microenvironment in patients with metastatic melanoma.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FPCMR.12172

Genome sequencing of mucosal melanomas reveals that they are driven by distinct mechanisms from cutaneous melanoma.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FPCMR.12172

Type, density, and location of immune cells within human colorectal tumors predict clinical outcome

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FPCMR.12172

How sunlight causes melanoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FPCMR.12172

Lesions to right prefrontal cortex impair real-world planning through premature commitments

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FPCMR.12172

The small GTPase ARF6 stimulates β-catenin transcriptional activity during WNT5A-mediated melanoma invasion and metastasis

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FPCMR.12172

The melanocyte differentiation program predisposes to metastasis after neoplastic transformation

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FPCMR.12172

Adhesion, migration and communication in melanocytes and melanoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FPCMR.12172

Frequent mutation of BAP1 in metastasizing uveal melanomas

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FPCMR.12172

Expression and functional significance of VE-cadherin in aggressive human melanoma cells: role in vasculogenic mimicry

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FPCMR.12172

A landscape of driver mutations in melanoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FPCMR.12172

Cancer stem cells versus phenotype-switching in melanoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FPCMR.12172

The L1 family of neural cell adhesion molecules: old proteins performing new tricks

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FPCMR.12172

International network of cancer genome projects

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FPCMR.12172

Regulatory T cells in melanoma: the final hurdle towards effective immunotherapy?

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FPCMR.12172

Microenvironmental regulation of metastasis

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FPCMR.12172

VEGFR1-positive haematopoietic bone marrow progenitors initiate the pre-metastatic niche

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FPCMR.12172

Next generation of immunotherapy for melanoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FPCMR.12172

Expression and function of the neural cell adhesion molecule L1 in mouse leukocytes

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FPCMR.12172

Exome sequencing identifies recurrent somatic RAC1 mutations in melanoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FPCMR.12172

Altered melanoma cell surface glycosylation mediates organ specific adhesion and metastasis via lectin receptors on the lung vascular endothelium

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FPCMR.12172

Strategies to counteract MHC-I defects in tumors

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FPCMR.12172

The seed and soil hypothesis revisited--the role of tumor-stroma interactions in metastasis to different organs

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FPCMR.12172

Autocrine VEGF signaling is required for vascular homeostasis

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FPCMR.12172

Surgery for distant melanoma metastasis

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FPCMR.12172

IL-8 directly enhanced endothelial cell survival, proliferation, and matrix metalloproteinases production and regulated angiogenesis

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FPCMR.12172

Transforming growth factor-beta regulation of immune responses

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FPCMR.12172

Reactive astrocytes protect melanoma cells from chemotherapy by sequestering intracellular calcium through gap junction communication channels

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FPCMR.12172

Galectins as modulators of tumour progression

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FPCMR.12172

Elucidating distinct roles for NF1 in melanomagenesis

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FPCMR.12172

RAS oncogenes: the first 30 years.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FPCMR.12172

Vascular channel formation by human melanoma cells in vivo and in vitro: vasculogenic mimicry

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FPCMR.12172

Ipilimumab in patients with melanoma and brain metastases: an open-label, phase 2 trial.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FPCMR.12172

Cellular adhesion pathways and metastatic potential of human melanoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FPCMR.12172

Bioimmunotherapy for melanoma using fully human antibodies targeting MCAM/MUC18 and IL-8.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FPCMR.12172

Inflammation and melanoma growth and metastasis: the role of platelet-activating factor (PAF) and its receptor

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FPCMR.12172

Transcriptional control of the melanoma malignant phenotype

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FPCMR.12172

Inflammation and melanoma metastasis

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FPCMR.12172

Crosstalk between protease-activated receptor 1 and platelet-activating factor receptor regulates melanoma cell adhesion molecule (MCAM/MUC18) expression and melanoma metastasis

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FPCMR.12172

CREB inhibits AP-2alpha expression to regulate the malignant phenotype of melanoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FPCMR.12172

Tumor cell plasticity and angiogenesis in human melanomas

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FPCMR.12172

Driving transcriptional regulators in melanoma metastasis

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FPCMR.12172

Human neural cell adhesion molecule L1 and rat homologue NILE are ligands for integrin alpha v beta 3

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FPCMR.12172

Expression profiling of Galectin-3-depleted melanoma cells reveals its major role in melanoma cell plasticity and vasculogenic mimicry

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FPCMR.12172

Lysophosphatidic acid induces lymphangiogenesis and IL-8 production in vitro in human lymphatic endothelial cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FPCMR.12172

Exome sequencing identifies recurrent somatic MAP2K1 and MAP2K2 mutations in melanoma.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FPCMR.12172

Activated leukocyte cell adhesion molecule: a new paradox in cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FPCMR.12172

Cross-species hybridization of microarrays for studying tumor transcriptome of brain metastasis

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FPCMR.12172

The secreted factors responsible for pre-metastatic niche formation: old sayings and new thoughts.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FPCMR.12172

Melanoma exosomes educate bone marrow progenitor cells toward a pro-metastatic phenotype through MET

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FPCMR.12172

Nonrandom chromosomal abnormalities in primary uveal melanoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FPCMR.12172

Autotaxin signaling via lysophosphatidic acid receptors contributes to vascular endothelial growth factor-induced endothelial cell migration.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FPCMR.12172

Transendothelial migration of melanoma cells involves N-cadherin-mediated adhesion and activation of the beta-catenin signaling pathway

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FPCMR.12172

Efficient tumour formation by single human melanoma cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FPCMR.12172

Human melanoma metastasis in NSG mice correlates with clinical outcome in patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FPCMR.12172

Membrane-derived microvesicles: important and underappreciated mediators of cell-to-cell communication

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FPCMR.12172

Markers of circulating tumour cells in the peripheral blood of patients with melanoma correlate with disease recurrence and progression

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FPCMR.12172

Ipilimumab plus dacarbazine for previously untreated metastatic melanoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FPCMR.12172

TGFbeta signalling in control of T-cell-mediated self-reactivity

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FPCMR.12172

Regulatory T cells and immune tolerance

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FPCMR.12172

Enhanced expression of vascular endothelial growth factor in metastatic melanoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FPCMR.12172

Role of cadherins in the transendothelial migration of melanoma cells in culture

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FPCMR.12172

Keratinocytes regulate melanocyte number in human fetal and neonatal skin equivalents

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FPCMR.12172

Proinvasion metastasis drivers in early-stage melanoma are oncogenes

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FPCMR.12172

CD40 ligation releases immature dendritic cells from the control of regulatory CD4+CD25+ T cells.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FPCMR.12172

Unravelling the complexity of metastasis - molecular understanding and targeted therapies

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FPCMR.12172

CTLA-4 is a direct target of Wnt/beta-catenin signaling and is expressed in human melanoma tumors

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FPCMR.12172

Isolation of Yucaipa virus

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FPCMR.12172

Inflammatory breast cancer: vasculogenic mimicry and its hemodynamics of an inflammatory breast cancer xenograft model

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FPCMR.12172

Cultured human melanocytes express the intermediate filament vimentin

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FPCMR.12172

21 January 2018

Cancer statistics, 2013

1 reference

https://api.crossref.org/works/10.1111%2FPCMR.12172

Host CXCR2-dependent regulation of melanoma growth, angiogenesis, and experimental lung metastasis

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FPCMR.12172

Cytogenetic findings in six posterior uveal melanomas: involvement of chromosomes 3, 6, and 8.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FPCMR.12172

Soluble melanoma cell adhesion molecule (sMCAM/sCD146) promotes angiogenic effects on endothelial progenitor cells through angiomotin

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FPCMR.12172

Frequent somatic mutations in MAP3K5 and MAP3K9 in metastatic melanoma identified by exome sequencing

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FPCMR.12172

Inefficient presentation of tumor-derived antigen by tumor-infiltrating dendritic cells.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FPCMR.12172

The BRAF-MAPK signaling pathway is essential for cancer-immune evasion in human melanoma cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FPCMR.12172

Activated leukocyte cell adhesion molecule (ALCAM/CD166): signaling at the divide of melanoma cell clustering and cell migration?

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FPCMR.12172

Understanding the melanocyte distribution in human epidermis: an agent-based computational model approach

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FPCMR.12172

Tumor masses support naive T cell infiltration, activation, and differentiation into effectors

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FPCMR.12172

Safety, activity, and immune correlates of anti-PD-1 antibody in cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FPCMR.12172

Activated leukocyte cell adhesion molecule/CD166, a marker of tumor progression in primary malignant melanoma of the skin

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FPCMR.12172

Attenuation of melanoma invasion by a secreted variant of activated leukocyte cell adhesion molecule

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FPCMR.12172

Frequent somatic mutations of GNAQ in uveal melanoma and blue naevi

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FPCMR.12172

Mutations in GNA11 in uveal melanoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FPCMR.12172

Signaling pathways in tumor vasculogenic mimicry

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FPCMR.12172

Targeting melanoma growth and metastasis with systemic delivery of liposome-incorporated protease-activated receptor-1 small interfering RNA.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FPCMR.12172

Overexpression of protease-activated receptor-1 contributes to melanoma metastasis via regulation of connexin 43.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FPCMR.12172

Protease activated receptor-1 inhibits the Maspin tumor-suppressor gene to determine the melanoma metastatic phenotype

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FPCMR.12172

21 January 2018

Cancer genome landscapes

1 reference

https://api.crossref.org/works/10.1111%2FPCMR.12172

Involvement of integrin alpha(v)beta(3) and cell adhesion molecule L1 in transendothelial migration of melanoma cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FPCMR.12172

Platelet-activating factor, a molecular sensor for cellular damage, activates systemic immune suppression

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FPCMR.12172

A Wnt-er migration: the confusing role of β-catenin in melanoma metastasis.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FPCMR.12172

Exome sequencing identifies GRIN2A as frequently mutated in melanoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FPCMR.12172

Selective BRAF inhibitors induce marked T-cell infiltration into human metastatic melanoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FPCMR.12172

Transcriptomic versus chromosomal prognostic markers and clinical outcome in uveal melanoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FPCMR.12172

Evolution of the cancer genome

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FPCMR.12172

Interferon-γ links ultraviolet radiation to melanomagenesis in mice

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FPCMR.12172

Expression of Id-1 is regulated by MCAM/MUC18: a missing link in melanoma progression

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FPCMR.12172

Galectin-3 Expression Is Associated with Tumor Progression and Pattern of Sun Exposure in Melanoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FPCMR.12172

A study of adhesion molecules as markers of progression in malignant melanoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FPCMR.12172

21 January 2018

Identifiers

DOI

10.1111/PCMR.12172

1 reference

29 August 2017

1 reference